CatalYm (private company)

See something wrong or missing? Let us know
Offices:Munich
Business model:B2B

CatalYm GmbH is a biopharmaceutical company developing novel cancer immunotherapies

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 59.05M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to CatalYm

Name Criteria
United Kingdom Achilles Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Forbion Capital Partners
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: BioGeneration Ventures
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Forbion Capital Partners
  • Total raised in a similar range: 10M+ USD
Ireland SynOx Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Forbion Capital Partners
  • Total raised in a similar range: 10M+ USD
Finland Rappta Therapeutics
58%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: Novartis Venture Fund
  • Total raised in a similar range: 10M+ USD
United Kingdom Abzena
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Germany Adrenomed AG
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Spain Algenex
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Top